![Fubao Wang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Fubao Wang currently works at Prime Medicine, Inc., as Senior VP & Head-Regulatory Affairs from 2022.
Dr. Wang also formerly worked at Merck & Co., Inc., as Director-Regulatory Affairs, Sarepta Therapeutics, Inc., as Vice President & Head-Regulatory, Sanofi, as Associate Vice President, and AskBio Inc., as Senior Vice President & Head-Regulatory Affairs.
Dr. Wang received his doctorate degree from Ruprecht-Karls-Universität Heidelberg and undergraduate degree and graduate degree from Nankai University.
Former positions of Fubao Wang
| Companies | Position | End |
|---|---|---|
| PRIME MEDICINE, INC. | General Counsel | 2025-02-28 |
| SANOFI | Corporate Officer/Principal | - |
| MERCK & CO., INC. | General Counsel | - |
| SAREPTA THERAPEUTICS, INC. | General Counsel | - |
AskBio Inc.
 AskBio Inc. BiotechnologyHealth Technology Engages in the development and delivery of novel protein and cellular based therapies | General Counsel | - |
Training of Fubao Wang
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
2
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
AskBio Inc.
AskBio Inc. BiotechnologyHealth Technology Engages in the development and delivery of novel protein and cellular based therapies | Health Technology |
Ruprecht-Karls-Universität Heidelberg
 Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nankai University
 Nankai University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
- Stock Market
- Insiders
- Fubao Wang
